{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:56:06Z","timestamp":1790722566006,"version":"4.1.0"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41391-026-01118-3","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:57:52Z","timestamp":1778605072000},"page":"911-912","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interpreting undetectable PSA and surveillance inference in post hoc ARAMIS analyses"],"prefix":"10.1038","volume":"29","author":[{"given":"Lei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4301-1076","authenticated-orcid":false,"given":"Dongxiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"1118_CR1","doi-asserted-by":"publisher","unstructured":"Morgans AK, Wallis CJD, Halabi S, Armstrong AJ, Adorjan P, Ghadessi M, et al. Disease progression patterns and association of prostate-specific antigen level with risk of progression in nonmetastatic castration-resistant prostate cancer. Prostate Cancer Prostatic Dis. 2026. https:\/\/doi.org\/10.1038\/s41391-026-01076-w.","DOI":"10.1038\/s41391-026-01076-w"},{"key":"1118_CR2","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1097\/JU.0000000000003452","volume":"209","author":"W Lowrance","year":"2023","unstructured":"Lowrance W, Dreicer R, Jarrard DF, Scarpato KR, Kim SK, Kirkby E, et al. Updates to advanced prostate cancer: AUA\/SUO guideline (2023). J Urol. 2023;209:1082\u201390. https:\/\/doi.org\/10.1097\/JU.0000000000003452.","journal-title":"J Urol"},{"key":"1118_CR3","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.euf.2025.03.019","volume":"11","author":"M Miszczyk","year":"2025","unstructured":"Miszczyk M, Fazekas T, Rajwa P, Matsukawa A, Tsuboi I, Leapman MS, et al. Prostate-specific antigen response as a prognostic factor for overall survival in patients with prostate cancer treated with androgen receptor pathway inhibitors: a systematic review and meta-analysis. Eur Urol Focus. 2025;11:755\u201366. https:\/\/doi.org\/10.1016\/j.euf.2025.03.019.","journal-title":"Eur Urol Focus"},{"key":"1118_CR4","doi-asserted-by":"publisher","first-page":"b5087","DOI":"10.1136\/bmj.b5087","volume":"340","author":"LE L\u00e9vesque","year":"2010","unstructured":"L\u00e9vesque LE, Hanley JA, Kezouh A, Suissa S. Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ. 2010;340:b5087 https:\/\/doi.org\/10.1136\/bmj.b5087.","journal-title":"BMJ"},{"key":"1118_CR5","doi-asserted-by":"publisher","unstructured":"Armstrong AJ, Azad AA, Iguchi T, Stenzl A, Mottet N, Russell D, et al. Radiographic progression with and without prostate-specific antigen rise in patients with advanced prostate cancer treated with enzalutamide. J Clin Oncol. 2026:JCO2402829. https:\/\/doi.org\/10.1200\/JCO-24-02829.","DOI":"10.1200\/JCO-24-02829"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01118-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01118-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01118-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:00:24Z","timestamp":1790719224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01118-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1118"],"URL":"https:\/\/doi.org\/10.1038\/s41391-026-01118-3","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"9 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Generative AI tools were used solely for language refinement and formatting assistance. All scientific interpretation, critique, and scholarly content were independently developed by the authors.","order":2,"name":"Ethics","label":"Artificial intelligence (AI) use disclosure","group":{"name":"EthicsHeading","label":"Ethics"}}]}}